The D2/D3 agonist PD128907 (R-(+)-trans-3,4a,10b-tetrahydro-4-Propyl-2H,5H- [1]benzopyrano[4,3-b]-1,4-oxazin-9-ol) inhibits stimulated pyloric relaxation and spontaneous gastric emptying

Digestive Diseases and Sciences

Volumn 54, Issue 1, 2009, Pages 57-62

  Kashyap, Purna ^a   Micci, Maria Adelaide ^a   Pasricha, Sarina ^a   Pasricha, Pankaj Jay ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine 3 receptor; Gastric emptying; Rat; Stomach

Indexed keywords

3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; DOPAMINE 3 RECEPTOR; NAFADOTRIDE; PHENOLSULFONPHTHALEIN;

ADULT ANIMAL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINE MUSCLE; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; PYLORUS; RAT; REGULATORY MECHANISM; SPRAGUE DAWLEY RAT; STOMACH EMPTYING; STOMACH MOTILITY;

ANIMALS; BENZOPYRANS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; MUSCLE RELAXATION; MYENTERIC PLEXUS; NAPHTHALENES; OXAZINES; PYLORUS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 58149305652     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0335-6     Document Type: Article

References (21)

1. P Sokoloff B Giros MP Martres ML Bouthenet JC Schwartz 1990 Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics Nature 347 146 151 10.1038/347146a0
2. RK Sunahara 1991 Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1 Nature 350 614 619 10.1038/350614a0
3. HH Van Tol 1991 Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine Nature 350 610 614 10.1038/350610a0
4. G Tougas M Anvari J Dent S Somers D Richards GW Stevenson 1992 Relation of pyloric motility to pyloric opening and closure in healthy subjects Gut 33 4 466 471 10.1136/gut.33.4.466
5. C Scarpignato T Capovilla G Bertaccini 1980 Action of caerulein on gastric emptying of the conscious rat Arch Int Pharmacodyn Ther 246 286 294
6. B Giros MP Martres C Pilon P Sokoloff JC Schwartz 1991 Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing Biochem Biophys Res Commun 176 1584 1592 10.1016/0006-291X(91)90469-N
7. LA Snyder JL Roberts SC Sealfon 1991 Alternative transcripts of the rat and human dopamine D3 receptor Biochem Biophys Res Commun 180 1031 1035 10.1016/S0006-291X(05)81169-6
8. TR Werkman JC Glennon WJ Wadman AC McCreary 2006 Dopamine receptor pharmacology: interactions with serotonin receptors and significance for the aetiology and treatment of schizophrenia CNS Neurol Disord Drug Targets 5 3 23
9. ZS Li TD Pham H Tamir JJ Chen MD Gershon 2004 Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation J Neurosci 24 1330 1339 10.1523/JNEUROSCI.3982-03.2004
10. M Anlauf MK Schafer L Eiden E Weihe 2003 Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes J Comp Neurol 459 90 111 10.1002/cne.10599
11. S Kurosawa WL Hasler G Torres JW Wiley C Owyang 1991 Characterization of receptors mediating the effects of dopamine on gastric smooth muscle Gastroenterology 100 1224 1231
12. T Takahashi S Kurosawa JW Wiley C Owyang 1991 Mechanism for the gastrokinetic action of domperidone. In vitro studies in guinea pigs Gastroenterology 101 703 710
13. SC Reddymasu I Soykan RW McCallum 2007 Domperidone: review of pharmacology and clinical applications in gastroenterology Am J Gastroenterol 102 9 2036 2045
14. RB Moreland 2004 Comparative pharmacology of human dopamine D(2)-like receptor stable cell lines coupled to calcium flux through Galpha(qo5) Biochem Pharmacol 68 761 772 10.1016/j.bcp.2004.05.019
15. M Tonini 2004 Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics Aliment Pharmacol Ther 19 379 390 10.1111/j.1365-2036.2004.01867.x
16. ZS Li C Schmauss A Cuenca E Ratcliffe MD Gershon 2006 Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice J Neurosci 26 2798 2807 10.1523/JNEUROSCI.4720-05.2006
17. F Sautel 1995 Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents J Pharmacol Exp Ther 275 1239 1246
18. B Levant NR Vansell 1997 In vivo occupancy of D2 dopamine receptors by nafadotride Neuropsychopharmacology 17 67 71 10.1016/S0893-133X(97)00024-9
19. S Sammut KE Bray AR West 2007 Dopamine D2 receptor-dependent modulation of striatal NO synthase activity Psychopharmacology (Berl) 191 793 803 10.1007/s00213-006-0681-z
20. N Yoshida T Yoshikawa K Hosoki 1995 A dopamine D3 receptor agonist, 7-OH-DPAT, causes vomiting in the dog Life Sci 57 PL347 PL350 10.1016/0024-3205(95)02186-M
21. T Yoshikawa N Yoshida K Hosoki 1996 Involvement of dopamine D3 receptors in the area postrema in R(+)-7-OH-DPAT-induced emesis in the ferret Eur J Pharmacol 301 143 149 10.1016/0014-2999(96)00061-1